| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $225.78M | - | |
| COO | 547.4K | $32.59M | - | |
| Other | 227.0K | $13.51M | - | |
| CFO | 162.9K | $9.70M | - | |
| Dir | 111.5K | $6.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2021 | Douglas B Given66 | Director | Sell | 4,000 | $76.08 | $304,320.00 | -3.2% | |
| Jan 4, 2021 | William D. Waddill | Director | Sell | 3,750 | $76.08 | $285,300.00 | -11.0% | |
| Jan 4, 2021 | Michael S Perry55 | Director | Sell | 4,000 | $76.09 | $304,360.00 | -4.3% | |
| Dec 17, 2020 | Douglas B Given66 | Director | Sell | 9,575 | $79.32 | $759,442.50 | -39.0% | |
| Dec 10, 2020 | William D. Waddill | Director | Sell | 3,000 | $71.26 | $213,780.00 | -10.7% | |
| Dec 9, 2020 | Christopher Richard Anzalone60 | Chief Executive Officer | Sale+OE | 55,000 | $68.73 | $3,780,347.33 | -2.1% | |
| Nov 20, 2020 | Curt Bradshaw | Chief Scientific Officer | Sell | 31,250 | $69.06 | $2,158,125.00 | -100% | |
| Nov 19, 2020 | Martin Javier San65 | Chief Medical Officer | Sell | 19,500 | $69.39 | $1,353,105.00 | -13.0% | |
| Nov 9, 2020 | Kenneth Allen Myszkowski68 | Chief Financial Officer | Sale+OE | 43,505 | $69.37 | $3,018,070.50 | -9.2% | |
| Oct 23, 2020 | Christopher Richard Anzalone60 | Chief Executive Officer | Sell | 100,000 | $58.21 | $5,821,031.52 | -3.8% |